Plus Therapeutics, Inc. | CYTX - Equity Capital And Reserves

Cytori Therapeutics reported $6.44M in Equity Capital and Reserves for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Equity Capital And Reserves Change
Baxter International BAX:US USD 5.83B 298M
Cerus CERS:US USD 67.61M 5.51M
Cytori Therapeutics CYTX:US USD 6.44M 4.96M
Haemonetics HAE:US USD 775.98M 46.97M
Infinity Pharmaceuticals INFI:US USD -10874000 9.77M
Merrimack Pharmaceuticals MACK:US USD 13.19M 425K
Mirati Therapeutics MRTX:US USD 996.52M 132.54M
Northwest Biotherapeutics NWBO:US USD -95104000 3.44M
Starpharma Holdings Ltd SPL:AU AUD 48.39M 6.69M
Teva Pharmaceutical TEVA:IT USD 7.9B 871M